Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Drug or technology

Avelumab

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 10, 2026 · PHASE 1/2 TRIAL

TALAVE: Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast Cancer

ClinicalTrials.gov

This is an active Phase 1/2 pilot trial with 24 participants designed to assess safety and tolerability; no results are posted in this registry record.

PreliminaryNCT03964532 Avelumab Talazoparib

Reported

Planned enrollment24

Primary outcome measureGrade 3 and 4 toxicities (Adverse Events) f…

Study phasePhase 1/2

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support